Valuation: NeuroPace, Inc.

Market Cap 446M 399M 369M 334M 625M 42.42B 635M 4.44B 1.76B 22.19B 1.67B 1.64B 70.25B P/E 2026 *
-25.3x
P/E 2027 * -49.8x
Enterprise Value 469M 419M 388M 351M 658M 44.63B 668M 4.67B 1.85B 23.34B 1.76B 1.72B 73.91B EV / Sales 2026 *
4.67x
EV / Sales 2027 * 3.77x
Free-Float
82.62%
Yield 2026 *
-
Yield 2027 * -
1 day-1.00%
1 week-4.37%
Current month-6.10%
1 month-8.69%
3 months-15.56%
6 months-25.10%
Current year-16.32%
1 week 12.64
Extreme 12.64
13.69
1 month 12.13
Extreme 12.13
14.45
Current year 12.13
Extreme 12.13
19.6
1 year 9.22
Extreme 9.22
19.6
3 years 5.45
Extreme 5.45
19.6
5 years 1.22
Extreme 1.22
19.6
10 years 1.22
Extreme 1.22
27.38
Manager TitleAgeSince
Chief Executive Officer 58 2023-07-09
Director of Finance/CFO 53 2025-06-19
Chief Tech/Sci/R&D Officer - 2024-09-03
Director TitleAgeSince
Director/Board Member 57 2012-12-31
Chairman 84 1997-11-30
Director/Board Member 46 2021-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/24/26 Tax

Chief Technology Officer

-335 0.0010%
9/20/26 Tax

Chief Financial Officer

-1,162 0.0034%
9/3/26 Tax

Chief Executive Officer

-1,310 0.0038%
Change 5-day change 1-year change 3-year change Capi.($)
-1.04%-4.37%+21.89%+106.39% 446M
+0.33%-1.36%+20.26%+57.16% 253B
-0.52%+2.80%+4.30%+22.69% 164B
-0.21%+2.59%-18.48%+73.51% 157B
-0.86%-0.79%-55.85%-8.68% 66.06B
-0.61%-0.76%+6.95%+66.87% 51.52B
-0.67%+1.33%-15.14%-8.44% 52.64B
-0.33%+1.66%+11.06%+45.45% 52.2B
+0.39%+0.86%+19.03%+69.79% 49.61B
+1.00%+2.15%+28.60%+84.81% 44.8B
Average -0.40%+2.77%+2.26%+50.96% 89.1B
Weighted average by Cap. -0.31%+2.65%+1.83%+46.93%

Financials

2026 *2027 *
Net sales 100M 89.73M 83.02M 75.17M 141M 9.55B 143M 999M 395M 4.99B 377M 369M 15.81B 122M 110M 101M 91.74M 172M 11.65B 175M 1.22B 482M 6.09B 460M 450M 19.3B
Net income -18.06M -16.15M -14.94M -13.53M -25.32M -1.72B -25.74M -180M -71.12M -899M -67.79M -66.34M -2.85B -8.98M -8.03M -7.43M -6.73M -12.59M -854M -12.79M -89.39M -35.36M -447M -33.7M -32.98M -1.41B
Net Debt 23.21M 20.76M 19.2M 17.39M 32.54M 2.21B 33.07M 231M 91.41M 1.16B 87.12M 85.26M 3.66B 16.02M 14.32M 13.25M 12M 22.46M 1.52B 22.82M 159M 63.08M 797M 60.12M 58.84M 2.52B
Projected Income Statement - Annual - NeuroPace, Inc.
Logo NeuroPace, Inc.
NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.
Employees
220
Date Price Change Volume
26-10-27 US$12.92 -0.54% 1,173
26-10-26 US$12.99 +0.62% 67,337
26-10-23 US$12.91 -1.75% 69,067
26-10-22 US$13.14 +0.69% 97,950
26-10-21 US$13.05 -3.40% 64,250
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - NeuroPace, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
12.99USD
Average target price
20.00USD
Spread / Average Target
+53.96%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - NeuroPace, Inc.
  1. Stock Market
  2. Stocks
  3. NPCE Stock